User banner image
User avatar
  • admin

Posts

Revolutionising Holiday Planning: SelfCatering.co.uk Surpasses 30,000 Properties

Lightwater, Surrey, Jan. 02, 2025 (GLOBE NEWSWIRE) — SelfCatering.co.uk, the UK’s premier website for finding holiday cottages and self-catering properties, is thrilled to announce a...

Govee Partners with IDC to Discuss the Impact of Smart Lighting and the Future of Smart Living In a New Whitepaper

In new research for CES 2025, Govee aims to illuminate the next generation of smart lighting solutions LAS VEGAS, Jan. 3, 2025 /PRNewswire/ — Govee,...

DataLend: 2024 Securities Lending Revenue Down 10% YoY to $9.64 Billion

Lending revenue dips against backdrop of record-high indices NEW YORK, Jan. 3, 2025 /PRNewswire/ — The global securities finance industry generated $9.64 billion in revenue...

CUBE COMPLETES ACQUISITION OF THOMSON REUTERS REGULATORY INTELLIGENCE AND ODEN BUSINESSES

Acquisition delivers an expanded customer base with a deep global subject matter expertise network that further powers CUBE’s RegBrain AI across its industry proven SaaS RegPlatform™...

CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across North America, Asia, Europe and the Middle East NEWPORT BEACH, Calif., Jan. 3, 2025 /PRNewswire/ — CathWorks,...

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 3, 2025 /PRNewswire/ — Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical...

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development

Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. &...

Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at...

Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer

WAYNE, Pa. and ROCKVILLE, Md., Jan. 02, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment...

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 02, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...